When a fragrance wafted through the bedrooms of older adults for two hours every night for six months, memories skyrocketed. Participants in this study by…
The passing of June’s summer solstice, the longest day of the year, prompts reflection on all of the ways people work to shine a light…
Results of a long-term study of cognitively healthy adults—most with a family history of Alzheimer’s disease—have added to evidence that low spinal fluid levels of…
A novel vaccine that targets inflamed brain cells associated with Alzheimer’s disease may hold the key to potentially preventing or modifying the course of the…
A new analysis of Australia’s disease burden reveals Australians are living six years longer than they were 30 years ago, but more people are being…
New Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning”—the worsening of the disease’s symptoms late in the day—and spur…
Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, associated with symptoms like memory loss and cognitive impairment. Brain lesions caused by…
Discrepancies in diagnostic biomarkers for Alzheimer’s Disease (AD) may arise from racial disparities, risk factors, or lifestyle differences. Moreover, there has been a lack of…
Transgender and nonbinary adults may be at higher risk of developing Alzheimer’s disease—the most common form of dementia—in later life, due to key risk factors…
Tau-regulating protein identified as a promising target for developing Alzheimer’s disease treatment
A gene encoding a protein linked to tau production—tripartite motif protein 11 (TRIM11)—was found to suppress deterioration in small animal models of neurodegenerative diseases similar…